| Scott Alan Scheinin, MD | |
|
6560 Fannin St, Suite 1750, Houston, TX 77030-2761 | |
| (713) 756-5314 | |
| (713) 756-8616 |
| Full Name | Scott Alan Scheinin |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 38 Years |
| Location | 6560 Fannin St, Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619977238 | NPI | - | NPPES |
| 133162108 | Medicaid | TX | |
| 89820B | Other | TX | BCBS |
| 8DW017 | Other | TX | BLUE CROSS BLUE SHIELD |
| 133162107 | Medicaid | TX | |
| P01298129 | Other | TX | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | H2763 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
News Archive
Cell Therapeutics, Inc. announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present end of study results for the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma at the 52nd Annual Meeting of the American Society of Hematology on Sunday, December 5, 2010 in Orlando, Florida.
A woman who suffers from post-traumatic stress disorder after escaping from her burning London flat has received more than £100,000 in compensation.
Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.
Red Herring's Top 100 Europe celebrates the exceptional accomplishments of technology companies and their position to grow at an explosive rate. The awards winners were announced today, and Nexstim has proudly been selected in this prestigious group as a Top 100 Europe.
› Verified 7 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
Cell Therapeutics, Inc. announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present end of study results for the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma at the 52nd Annual Meeting of the American Society of Hematology on Sunday, December 5, 2010 in Orlando, Florida.
A woman who suffers from post-traumatic stress disorder after escaping from her burning London flat has received more than £100,000 in compensation.
Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.
Red Herring's Top 100 Europe celebrates the exceptional accomplishments of technology companies and their position to grow at an explosive rate. The awards winners were announced today, and Nexstim has proudly been selected in this prestigious group as a Top 100 Europe.
› Verified 7 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626560 PECOS PAC ID: 2264691070 Enrollment ID: O20121218000412 |
News Archive
Cell Therapeutics, Inc. announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present end of study results for the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma at the 52nd Annual Meeting of the American Society of Hematology on Sunday, December 5, 2010 in Orlando, Florida.
A woman who suffers from post-traumatic stress disorder after escaping from her burning London flat has received more than £100,000 in compensation.
Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.
Red Herring's Top 100 Europe celebrates the exceptional accomplishments of technology companies and their position to grow at an explosive rate. The awards winners were announced today, and Nexstim has proudly been selected in this prestigious group as a Top 100 Europe.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Alan Scheinin, MD Po Box 3567, Houston, TX 77253-3567 Ph: (713) 790-5227 | Scott Alan Scheinin, MD 6560 Fannin St, Suite 1750, Houston, TX 77030-2761 Ph: (713) 756-5314 |
News Archive
Cell Therapeutics, Inc. announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present end of study results for the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma at the 52nd Annual Meeting of the American Society of Hematology on Sunday, December 5, 2010 in Orlando, Florida.
A woman who suffers from post-traumatic stress disorder after escaping from her burning London flat has received more than £100,000 in compensation.
Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.
Red Herring's Top 100 Europe celebrates the exceptional accomplishments of technology companies and their position to grow at an explosive rate. The awards winners were announced today, and Nexstim has proudly been selected in this prestigious group as a Top 100 Europe.
› Verified 7 days ago
Dr. Michael S Sweeney, M.D., Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 6400 Fannin St, Ste 3000, Houston, TX 77030 Phone: 713-790-0841 Fax: 713-790-1350 | |
Eyal E Porat, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1200 Binz St Ste 900, Houston, TX 77004 Phone: 713-522-0220 Fax: 833-989-1160 | |
Stephen G. Swisher, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
Dr. Steven B. Eisenberg, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 6411 Fannin St, Houston, TX 77030 Phone: 713-850-1190 Fax: 713-850-1327 | |
Mahesh Ramchandani, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 6550 Fannin St, Suite 1401, Houston, TX 77030 Phone: 713-441-5200 Fax: 713-793-7428 | |
David A. Ott, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 1101 Bates Ave, P115, Houston, TX 77030 Phone: 832-355-4900 Fax: 832-355-3770 | |
Ara A. Vaporciyan, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 |